Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calogero Cammà

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|October 13, 2017
Direct antiviral agents and risk of HCC: Waiting for GodotCalogero Cammà, Gioacchino Leandro
Clinics in Liver Disease|April 16, 2005
Prevention of hepatocellular carcinomaAntonio Craxì, Calogero Cammà
United European Gastroenterology Journal|May 26, 2021
Young gastrointestinal angle: E-learning in gastroenterology: Future is nowMarcello Maida, Calogero Cammà
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzleCiro Celsa, Calogero Cammà
Journal of Hepatology|November 19, 2005
Treating patients with HCV genotype 1 and low viraemia: more than meets the eyeAntonio Craxì, Calogero Cammà
Journal of Hepatology|February 24, 2009
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureCalogero Cammà, Salvatore Petta
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2009
Prognostic scores for hepatocellular carcinoma: none is the winnerCalogero Cammà, Giuseppe Cabibbo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Does chemotherapy prevent HCV-related hepatocellular carcinoma? ConsAntonio Craxì, Calogero Cammà
Hepatobiliary Surgery and Nutrition|February 27, 2014
Chemoprevention for hepatocellular carcinoma: the role of statinsGiuseppe Cabibbo, Salvatore Petta, Calogero Cammà
Journal of Hepatology|June 4, 2016
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothingCalogero Cammà, Giuseppe Cabibbo, Antonio Craxì
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|October 13, 2017
Direct antiviral agents and risk of HCC: Waiting for GodotCalogero Cammà, Gioacchino Leandro
Clinics in Liver Disease|April 16, 2005
Prevention of hepatocellular carcinomaAntonio Craxì, Calogero Cammà
United European Gastroenterology Journal|May 26, 2021
Young gastrointestinal angle: E-learning in gastroenterology: Future is nowMarcello Maida, Calogero Cammà
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzleCiro Celsa, Calogero Cammà
Journal of Hepatology|November 19, 2005
Treating patients with HCV genotype 1 and low viraemia: more than meets the eyeAntonio Craxì, Calogero Cammà
Journal of Hepatology|February 24, 2009
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureCalogero Cammà, Salvatore Petta
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2009
Prognostic scores for hepatocellular carcinoma: none is the winnerCalogero Cammà, Giuseppe Cabibbo
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Does chemotherapy prevent HCV-related hepatocellular carcinoma? ConsAntonio Craxì, Calogero Cammà
Hepatobiliary Surgery and Nutrition|February 27, 2014
Chemoprevention for hepatocellular carcinoma: the role of statinsGiuseppe Cabibbo, Salvatore Petta, Calogero Cammà
Journal of Hepatology|June 4, 2016
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothingCalogero Cammà, Giuseppe Cabibbo, Antonio Craxì
Pageof 21